Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC?
暂无分享,去创建一个
L. Larocca | F. Schmitt | E. Rossi | G. Fadda | T. Bizzarro
[1] T. Cenci,et al. Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience , 2014, Cancer cytopathology.
[2] M. Prasad,et al. Morphology predicts BRAFV600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study , 2014, Virchows Archiv.
[3] L. Larocca,et al. BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma , 2013, Cancer cytopathology.
[4] J. Bartek,et al. Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene , 2013, Oncotarget.
[5] S. Roman,et al. Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct , 2012, Histopathology.